Michael A. Schneider

Michael A. Schneider has a strong background in compliance, auditing, and risk management. Michael A. is currently serving as the Vice President of Global Compliance Auditing and Monitoring and ERM at Amicus Therapeutics. Before this role, they held positions as the Executive Director of Global Auditing and Monitoring and Enterprise Risk Management, and Senior Director of Global Head of Compliance and Enterprise Risk Management at the same company. Prior to joining Amicus Therapeutics, Schneider worked at NPS Pharma as the Executive Director of Enterprise Risk Management, Internal Audit, and Compliance. Michael A. also served as a Partner at ParenteBeard LLC, where they were responsible for consulting in corporate governance and risk management practices. Schneider has experience in the pharmaceutical industry, having worked at Ikaria, ImClone Systems Inc., Pharmacia, and Merck and Company in various management roles. Michael A. began their career as an Audit Manager in the healthcare practice at Ernst and Young, LLC.

Michael A. Schneider attended Rutgers University - Newark from 1986 to 1990, where they received a Bachelor of Science (BS) degree in Accounting. Michael A. also holds a certification as a Certified Public Accountant.